ArticleJournal of clinical medicine2025

Successful Switch to Obinutuzumab in a Rituximab-Intolerant Child with Difficult-to-Treat Idiopathic Nephrotic Syndrome.

Magdalena Drozynska-Duklas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.